309 related articles for article (PubMed ID: 25900102)
1. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
2. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
3. Impact of a pharmacist-led oral chemotherapy-monitoring program in patients with metastatic castrate-resistant prostate cancer.
Patel JM; Holle LM; Clement JM; Bunz T; Niemann C; Chamberlin KW
J Oncol Pharm Pract; 2016 Dec; 22(6):777-783. PubMed ID: 26493871
[TBL] [Abstract][Full Text] [Related]
4. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
Umar RM; Apikoglu-Rabus S; Yumuk PF
Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
[TBL] [Abstract][Full Text] [Related]
5. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
Lam MS; Cheung N
J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
[TBL] [Abstract][Full Text] [Related]
6. Impact of a formal pharmacist-run oral antineoplastic monitoring program: A pilot study in an adult genitourinary oncology clinic.
Conliffe B; Figg L; Moffett P; Lauterwasser L; Parsons LB
J Oncol Pharm Pract; 2019 Jun; 25(4):777-786. PubMed ID: 29375014
[TBL] [Abstract][Full Text] [Related]
7. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
Snider M; Kalbfleisch S; Carnes CA
Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of pharmacist interventions in an ambulatory palliative care practice.
Ma JD; Tran V; Chan C; Mitchell WM; Atayee RS
J Oncol Pharm Pract; 2016 Dec; 22(6):757-765. PubMed ID: 26428283
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Feasibility and Utility of a Pharmacist-Centered Collaborative Drug Therapy Management Program for Oncology-Based Symptom Management.
Hansen EA; Pietkiewicz JM; Blum BL
J Pharm Pract; 2016 Jun; 29(3):206-11. PubMed ID: 25510586
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
[TBL] [Abstract][Full Text] [Related]
12. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
[TBL] [Abstract][Full Text] [Related]
13. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
[TBL] [Abstract][Full Text] [Related]
14. Implementation and evaluation of a shared care model between oncologists and pharmacists for breast cancer patients at a Canadian regional ambulatory cancer centre.
Goh E; Labelle S; Chan A
J Oncol Pharm Pract; 2024 Jun; 30(4):622-627. PubMed ID: 37259570
[TBL] [Abstract][Full Text] [Related]
15. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?
Ruder AD; Smith DL; Madsen MT; Kass FH
J Oncol Pharm Pract; 2011 Dec; 17(4):425-32. PubMed ID: 21248174
[TBL] [Abstract][Full Text] [Related]
16. Development of a pharmacist-psychiatrist collaborative medication therapy management clinic.
Tallian KB; Hirsch JD; Kuo GM; Chang CA; Gilmer T; Messinger M; Chan P; Daniels CE; Lee KC
J Am Pharm Assoc (2003); 2012; 52(6):e252-8. PubMed ID: 23229987
[TBL] [Abstract][Full Text] [Related]
17. Characterization of pharmacist-based medication management services in a community pharmacy.
Salmasi S; Tsao NW; Li K; Shaske JN; Marra CA; Lynd LD
Res Social Adm Pharm; 2020 Feb; 16(2):178-182. PubMed ID: 31060791
[TBL] [Abstract][Full Text] [Related]
18. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
[TBL] [Abstract][Full Text] [Related]
19. Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents.
Ribed A; Escudero-Vilaplana V; Romero-Jimenez RM; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo-Saez M
Expert Opin Drug Saf; 2016; 15(4):427-35. PubMed ID: 26854363
[TBL] [Abstract][Full Text] [Related]
20. Impact of clinical pharmacists in outpatient oncology practices: A review.
Gatwood J; Gatwood K; Gabre E; Alexander M
Am J Health Syst Pharm; 2017 Oct; 74(19):1549-1557. PubMed ID: 28947527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
